Management Review
What a definition is not
A definition is SPEQ’s plain-language decode of how a term is used in practice, cited to the documents that define it. It is a practitioner reference, not legal or regulatory advice, it does not replace the definition in the source, and where a regulator’s wording differs the regulator’s wording governs.
Management review is the structured, periodic evaluation by senior management of the performance and continuing suitability of the pharmaceutical quality system, using defined inputs to drive decisions and actions. Inputs typically include quality metrics and trends, CAPA status and effectiveness, deviations and complaints, change management, audit and inspection outcomes, product quality reviews, and follow-up on prior actions. It is the mechanism that makes senior management accountable for the quality system rather than merely nominally responsible.
In the ICH Q10 model, management review is one of the four lifecycle-spanning elements and the point at which the monitoring–CAPA–change loop is closed by leadership: signals rise to management, and management commits resources and decisions in response. Weak management review — attendance without decisions, or inputs without follow-up — is a common maturity gap.
Effective reviews are evidenced by documented decisions, assigned owners, and tracked actions, not just minutes confirming a meeting took place.
- —Periodic senior-management evaluation of PQS performance and suitability
- —Inputs: metrics, CAPA, deviations, complaints, changes, audits, PQRs
- —One of the four ICH Q10 elements; closes the oversight loop
- —Evidenced by decisions, owners, and tracked actions — not minutes alone
ICH Q10 management-review provisions; EU GMP Chapter 1 (Pharmaceutical Quality System).
Frequently asked questions
What is Management Review?
Management review is the structured, periodic evaluation by senior management of the performance and continuing suitability of the pharmaceutical quality system, using defined inputs to drive decisions and actions. Inputs typically include quality metrics and trends, CAPA status and effectiveness, deviations and complaints, change management, audit and inspection outcomes, product quality reviews, and follow-up on prior actions. It is the mechanism that makes senior management accountable for the quality system rather than merely nominally responsible.
Which regulations cover Management Review?
ICH Q10 management-review provisions; EU GMP Chapter 1 (Pharmaceutical Quality System).